Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eddie Cy Wang

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
The Journal of Clinical Investigation|March 1, 2022
Concerns over functional experiments, interpretation, and required controlsEddie Cy Wang, Ceri A Fielding, Richard J Stanton
Antiviral Chemistry & Chemotherapy|January 8, 2010
The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral propertiesJitka Holcakova, Peter Tomasec, Joachim J Bugert, et al.
JCI Insight|June 20, 2023
Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2Michael D Grant, Kirsten Bentley, Ceri A Fielding, et al.
The Journal of Clinical Investigation|September 8, 2022
CD200 ectodomain shedding into the tumor microenvironment leads to NK cell dysfunction and apoptosisHuw J Morgan, Elise Rees, Simone Lanfredini, et al.
Elife|December 25, 2019
Human cytomegalovirus interactome analysis identifies degradation hubs, domain associations and viral protein functionsLuis V Nobre, Katie Nightingale, Benjamin J Ravenhill, et al.
The Journal of Clinical Investigation|February 15, 2021
Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirusVirginia-Maria Vlahava, Isa Murrell, Lihui Zhuang, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
The Journal of Clinical Investigation|March 1, 2022
Concerns over functional experiments, interpretation, and required controlsEddie Cy Wang, Ceri A Fielding, Richard J Stanton
Antiviral Chemistry & Chemotherapy|January 8, 2010
The inhibitor of cyclin-dependent kinases, olomoucine II, exhibits potent antiviral propertiesJitka Holcakova, Peter Tomasec, Joachim J Bugert, et al.
JCI Insight|June 20, 2023
Combined anti-S1 and anti-S2 antibodies from hybrid immunity elicit potent cross-variant ADCC against SARS-CoV-2Michael D Grant, Kirsten Bentley, Ceri A Fielding, et al.
The Journal of Clinical Investigation|September 8, 2022
CD200 ectodomain shedding into the tumor microenvironment leads to NK cell dysfunction and apoptosisHuw J Morgan, Elise Rees, Simone Lanfredini, et al.
Elife|December 25, 2019
Human cytomegalovirus interactome analysis identifies degradation hubs, domain associations and viral protein functionsLuis V Nobre, Katie Nightingale, Benjamin J Ravenhill, et al.
The Journal of Clinical Investigation|February 15, 2021
Monoclonal antibodies targeting nonstructural viral antigens can activate ADCC against human cytomegalovirusVirginia-Maria Vlahava, Isa Murrell, Lihui Zhuang, et al.
Pageof 1